医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

CLINICAL STUDY IN ACCELERATED HYPERFRACTIONATED IRRADIATION IN THE TREATMENT OF LOCAL ADVANCED NON-SMALL CELL LUNG CANCER

摘要Objective To evaluate the effect of accelerated hyperfractionated irradiation ( AHFI ) and conventional fractionated irradiation (CFI) for local advanced non-small cell lung cancer (NSCLC). Methods The patients of AHFI group were irradiated to large-field target volume by a daily fraction of 2Gy , and small-field target volume by a daily fraction of 1Gy with more than 6h interval. The total dose of largefield target volume was 50Gy /25Fx/5W and of small-field target volume was 75Gy /50Fx/5W. The patients in CFI group were irradiated by a daily fraction of 2Gy to the total dose of 66Gy /33Fx/6. 6W. After 3 months of radiotherapy, the tumor response rates of complete recovery ( CR ), partial recovery ( PR ), and no change ( NC ) and 1- and 2- year survival rate in the two groups were observed. Results The tumor response rates of CR, PR, NC in AHFI group and CFI group were 22.9% (8/35), 60.0% (21/35), 17.1% (6/35) and 11.4% (4/35), 51.4% (18/35), 37.2% (13/35) respectively (P>0.05). All patients were followed up 2 years or more. The 1- and 2- year survival rates in AHFI group and CFI group were 62.9% (22/35 ), 31.4 % ( 11/35) and 42.9% (15/35) , 17.1% (6/35) respectively (P<0.05). The incidences of esophagi tis and pneumonitisin AHFI group and CFI group were 34.3% (12/35), 22.9% (8/35) and 40.0% ( 14/35 ), 17.1%(6/35)(P>0.05). Conclusion In comparison with CFI, AHFI may increase 1- and 2- year survival rate after treatment of local advanced non-small cell lung cancer, while the radio-reactions, either early or late, did not increase significantly.

更多
广告
分类号 R73(肿瘤学)
DOI 10.3969/j.issn.1674-8123.2001.01.014
发布时间 2004-01-08(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览75
  • 下载0
上海第二医科大学学报(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷